Crystalline methamphetamine use and methamphetamine-related harms in Australia

Drug and Alcohol Review

Volumn 36, Issue 2, 2017, Pages 160-170

  Degenhardt, Louisa ^a   Sara, Grant ^b   McKetin, Rebecca ^c   Roxburgh, Amanda ^a   Dobbins, Timothy ^a   Farrell, Michael ^a   Burns, Lucinda ^a   Hall, Wayne D ^d,e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CURTIN UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

amphetamine type stimulants; dependence; injecting; methamphetamine; psychosis

Indexed keywords

METHAMPHETAMINE; MIDOMAFETAMINE; STREET DRUG;

AMPHETAMINE DEPENDENCE; AUSTRALIA; COMPLICATION; CRIME; HOSPITALIZATION; HOTLINE; HUMAN; QUESTIONNAIRE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AMPHETAMINE-RELATED DISORDERS; AUSTRALIA; CRIME; HOSPITALIZATION; HOTLINES; HUMANS; LINEAR MODELS; METHAMPHETAMINE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; STREET DRUGS; SURVEYS AND QUESTIONNAIRES;

EID: 84977543794     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12426     Document Type: Article

References (61)

1. UNODC. World Drug Report 2015. Vienna: United Nations, 2015.
2. McKetin R, Kelly E, McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug Alcohol Depend 2006;85:198–204.
3. Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008;27:253–62.
4. Mcketin R, Hickey K, Devlin K, Lawrence K. The risk of psychotic symptoms associated with recreational methamphetamine use. Drug Alcohol Rev 2010;29:358–63.
5. McKetin R, McLaren J, Lubman DI, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006;101:1473–8.
6. Farrell M, Marsden J, Ali R, Ling W. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 2002;97:771–2.
7. Degenhardt L, Roxburgh A, McKetin R. Hospital separations for cannabis- and methamphetamine-related psychotic episodes in Australia. Med J Aust 2007;186:342–5.
8. Hartel-Petri R, Rodler R, Schmeisser U, Steinmann J, Wolfersdorf M. Increasing prevalence of amphetamine--and methamphetamine-induced psychosis. Psychiatr Prax 2005;32:13–7.
9. Kaye S, McKetin R, Duflou J, Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007;102:1204–11.
10. McKetin R, McLaren J, Riddell S, Robins L. The relationship between methamphetamine use and violent behaviour. Crime and Justice Bulletin No. 97 Sydney: Bureau of Crime Statistics and Research, 2006.
11. McKetin R, McLaren J, Kelly E. The Sydney methamphetamine market: patterns of supply, use, personal harms and social consequences, NDLERF Monograph No. 13. Sydney: National Drug and Alcohol Research Centre, University of NSW, 2005.
12. Shoptaw S, Reback C. Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions. Addiction 2007;102:130–5.
13. Braine N, Des Jarlais DC, Goldblatt C, Zadoretzky C, Turner C. HIV risk behavior among amphetamine injectors at U.S. syringe exchange programs. AIDS Educ Prev 2005;17:515–24.
14. De Letter EA, Piette MH, Lambert WE, Cordonnier JA. Amphetamines as potential inducers of fatalities: a review in the district of Ghent from 1976–2004. Med Sci Law 2006;46:37–65.
15. Degenhardt L, Roxburgh A, Barker B. Underlying causes of cocaine, amphetamine and opioid related deaths in Australia. J Clin Forensic Med 2005;12:187–95.
16. Degenhardt L, Baxter A, Lee Y-Y, et al. The epidemiology and burden of disease attributable to psychostimulant dependence: findings from the Global Burden of Disease study 2010. Drug Alcohol Depend 2014;137:36–47.
17. McKetin R, Kozel N, Douglas J, et al. The rise of methamphetamine in Southeast and East Asia. Drug Alcohol Rev 2008;27:220–8.
18. Cho AK. Ice: a new dosage form of an old drug. Science 1990;249:631–4.
19. Cook CE, Jeffcoat AR, Hill JM, et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 1993;21:717–23.
20. Matsumoto T, Kamijo A, Miyakawa T, et al. Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. Addiction 2002;97:809–17.
21. McKetin R, Ross J, Kelly E, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev 2008;27:277–85.
22. Lancaster K, Ritter A, Colebatch H. Problems, policy and politics: making sense of Australia's ‘ice epidemic’. Policy Studies 2014;35:147–71.
23. Topp L, Degenhardt L, Kaye S, Darke S. The emergence of potent forms of methamphetamine in Sydney, Australia; a case study of the IDRS as a strategic early warning system. Drug Alcohol Rev 2002;21:341–8.
24. Wardlaw G. Supply reduction (law enforcement) strategies pertaining to illicit use of psychostimulants. In: Burrows D, Flaherty B, Mac Avoy M, eds. Illicit psychostimulant use in Australia. Canberra: Australian Government Publishing Service, 1993:91–104.
25. Degenhardt L, Roxburgh A, Black E, et al. The epidemiology of methamphetamine use and harm in Australia. Drug Alcohol Rev 2008;27(3):243–52.
26. Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Sydney. Aust Drug Alcohol Rev 1994;13:277–84.
27. Australian Broadcasting Commission. Australia's war on ice. 2015; Available from: http://www.abc.net.au/news/story-streams/ice-epidemic/.
28. Special Broadcasting Service. Ice Towns. 2015; Available from: http://www.sbs.com.au/icetowns/.
29. Hildebrand J. Ice epidemic could bring nation to its knees. 2015; Available from: http://www.dailytelegraph.com.au/ice-epidemic-could-bring-nation-to-its-knees-warns-nsw-police-commissioner-andrew-scipione/story-e6freuy9-1227285222295.
30. Australian Government. Ice Destroys Lives (Ad Campaign). 2015; Available from: http://www.drugs.health.gov.au/internet/drugs/publishingcp.nsf/content/home.
31. Department of Prime Minister and Cabinet. National Ice Task Force, Terms of Reference. 2015 [21/7/2015]; Available from: http://www.dpmc.gov.au/taskforces/national-ice-taskforce/terms-reference.
32. Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2004 – detailed findings. Canberra: Australian Institute of Health and Welfare, 2005.
33. Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2007 – detailed findings. Canberra: Australian Institute of Health and Welfare, 2008.
34. Australian Institute of Health and Welfare. National Drug Strategy Household Survey 2010 – detailed findings. Canberra: Australian Institute of Health and Welfare, 2011.
35. Australian Institute of Health and Welfare. 2013 National Drug Strategy Household Survey: first results. Canberra: Australian Institute of Health and Welfare, 2014.
36. Stafford J, Burns L. Australia Drug Trends 2014: findings from the Illicit Drug Reporting System (IDRS), Australian Drug Trends Series No. 127. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2015.
37. Sindicich N, Burns L. Australian trends in ecstasy and related drug markets 2013: findings from the Ecstasy and Related Drugs Reporting System (EDRS), Australian Drug Trends Series No. 136. Sydney: National Drug and Alcohol Research Centre, University of New South Wales, 2015.
38. Zeileis A, Leisch F, Hornik K, Kleiber C. strucchange: an R package for testing for structural change in linear regression models. 2001.
39. Pinheiro J, Bates D, DebRoy S, Sarkar D, R Core Team. nlme: linear and nonlinear mixed effects models. R package version 3.1-121. (nd). http://CRAN.R-project.org/package=nlme2015.
40. McKetin R, McLaren J, Kelly E, Hickman M, Hall W. Estimating the number of regular and dependent methamphetamine users in Australia. NDARC Technical Report No. 230. Sydney: National Drug and Alcohol Research Centre; 2005.
41. Degenhardt L, Larney S, Chan G, et al. Estimating the number of regular and dependent methamphetamine users in Australia. Med J Aust 2016;204:153.
42. Hall WD, Ross JE, Lynskey MT, Law MG, Degenhardt LJ. How many dependent heroin users are there in Australia? Med J Aust 2000;173:528–31.
43. Hall W, Ross J, Lynskey M, Law M, Degenhardt L. How many dependent heroin users are there in Australia? NDARC Monograph No. 44. National Drug and Alcohol Research Centre, UNSW: Sydney, 2000.
44. Chalmers J, Lancaster K, Hughes C. The stigmatisation of ‘ice’ and underreporting of methamphetamine use in general population surveys: a case study from Australia. Int J Drug Policy under review.
45. Australian Institute of Health and Welfare. Trends in methylamphetamine availability, use and treatment, 2003–04 to 2013–14. Canberra: Australian Institute of Health and Welfare. http://www.aihw.gov.au/publication-detail/?id=60129552818&tab=2 Accessed on 18 January 2016, 2015.
46. Nathan S, Bethmont A, Rawstorne P, Ferry M, Hayen A. Trends in drug use among adolescents admitted to residential treatment in Australia. Med J Aust 2016;204:149–50.
47. Bureau of Crime Statistics and Research. NSW Recorded Crime Statistics Quarterly Update September 2015. Sydney: Bureau of Crime Statistics and Research. http://www.bocsar.nsw.gov.au/Pages/bocsar_media_releases/2015/Media-Release-NSW-Recroded-Crime-Statistics-Sep-2015.aspx Accessed on 18 January 2016, 2015.
48. Scott N, Caulkins JP, Ritter A, Quinn C, Dietze P. High-frequency drug purity and price series as tools for explaining drug trends and harms in Victoria, Australia. Addiction 2015;110:120–8.
49. Swift W, Maher L, Sunjic S. Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia. Addiction 1999;94:71–82.
50. Lai F, O'Brien J, Thai P, Hall W, Mueller J. Trends in methamphetamine residues in wastewater in metropolitan and regional cities in South East Queensland 2009–2015. Med J Aust 2016;204:151–2.
51. NSW Government Department of Finance Services and Innovation. Digital+ 2016. NSW Government Digital Strategy Final Update. Sydney: NSW Government, 2015.
52. Australian Government Department of the Prime Minister and Cabinet. Public sector data management. Canberra: Commonwealth of Australia, 2015.
53. Shoptaw S, Klausner JD, Reback CJ, et al. A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence. BMC Public Health 2006;6:214.
54. Baker A, Lee N, Jenner J. Models of intervention and care for psychostimulant users, 2nd edn, NDS Monograph Series No. 51. Australian Government Department of Health and Ageing: Canberra, 2004.
55. Shoptaw S, Montgomery B, Williams CT, et al. Not just the needle: the state of HIV prevention science among substance users and future directions. J Acquir Immune Defic Syndr 2013;63:S174–8.
56. Shoptaw S, Reback CJ, Frosch DL, Rawson RA. Stimulant abuse treatment as HIV prevention. J Addict Dis 1998;17:19–32.
57. Rawson RA, Washton A, Domier CP, Reiber C. Drugs and sexual effects: role of drug type and gender. J Subst Abuse Treat 2002;22:103–8.
58. Bunting PJ, Fulde GW, Forster SL. Comparison of crystalline methamphetamine (‘ ice’) users and other patients with toxicology-related problems presenting to a hospital emergency department. Med J Aust 2007;187:564.
59. Shoptaw SJ, Kao U, Ling W. Treatment for amphetamine psychosis. Cochrane Database Syst Rev 2009;1.
60. Mathias S, Lubman DI, Hides L. Substance-induced psychosis: a diagnostic conundrum. J Clin Psychiatry 2008;69:358–367.
61. Degenhardt L, Day C, Gilmour S, Hall W. Patterns of illicit drug use in NSW, Australia following a reduction in heroin supply. Int J Drug Policy 2005;16:300–7.